/PRNewswire/ Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will.
Evoke Wealth LLC purchased a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,657 shares of the biopharmaceutical company’s stock, valued at approximately $1,355,000. A number of other […]
TD Asset Management Inc Increases Stake in Halozyme Therapeutics, Inc (NASDAQ:HALO) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc (NASDAQ:HALO) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Bernzott Capital Advisors trimmed its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 27.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 124,979 shares of the biopharmaceutical company’s stock after selling 46,829 shares during the quarter. Bernzott Capital Advisors’ holdings in Halozyme Therapeutics were worth $4,619,000 at the end of […]